SCHEMBL5203441

SCHEMBL5203441

CC(=O)ON1CCC(Cc2ccccc2F)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.46
HTR2A P28223 1/20 0.46
HRH1 P35367 1/20 0.46
ATM Q13315 1/20 0.46
NLN Q9BYT8 2/20 0.44
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPK14 Q16539 1/20 0.43
KMT2A Q03164 2/20 0.43
GRIN2B Q13224 3/20 0.42
F2 P00734 1/20 0.41
GRIN1 Q05586 1/20 0.41
CCR3 P51677 2/20 0.41
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
POLB P06746 1/20 0.40
MEN1 O00255 1/20 0.40
RAB9A P51151 1/20 0.40
MAPK1 P28482 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20502324 0.83 CYP2C9 (0.53) DRD2HTR2AHRH1ATMNLN
SCHEMBL5373262 0.80 ALDH1A1 (0.56) CYP2C9CYP2C19MAPK14KMT2ACCR3
SCHEMBL5206501 0.78 OPRM1 (0.49) KMT2ACCR3POLBMEN1
SCHEMBL28329339 0.77 EPHX2 (0.57) DRD2HTR2AHRH1ATMNLN
SCHEMBL5205363 0.76 F2 (0.44) KMT2AGRIN2BF2GRIN1POLB
SCHEMBL16825244 0.75 GPR119 (0.60) NLNKMT2AGRIN2BKDM4EMEN1
SCHEMBL5240588 0.75 ATM (0.58) DRD2HTR2AHRH1ATMNLN
SCHEMBL3813779 0.74 HRH3 (0.49) CYP2C9CYP2C19MAPK14KMT2AALDH1A1
SCHEMBL27953556 0.74 ATM (0.53) DRD2HTR2AHRH1ATMNLN
SCHEMBL5206103 0.73 OPRM1 (0.49) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1565453-A4 2- (4-BENZYL)-1-PIPERIDINYL)METHYL|BENZIMIDAZOLE-5-OL DERIVATIVES AS NR2B RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2007-10-10 EP disclosed
EP-1565453-A1 2- (4-BENZYL)-1-PIPERIDINYL)METHYL]BENZIMIDAZOLE-5-OL DERIVATIVES AS NR2B RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2005-08-24 EP disclosed
WO-2004048364-A1 2-[(4-BENZYL)-1-PIPERIDINYL)METHYL]BENZIMIDAZOLE-5-OL DERIVATIVES AS NR2B RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2004-06-10 WO disclosed